ArticleLeukemia research reports2025

Nivolumab for relapsed and refractory classical Hodgkin lymphoma: retrospective single center analysis.

Magdalena Witkowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.